Table 10 Summary statistics for surgery for patients receiving systemic therapy
From: The cost of unresectable stage III or stage IV melanoma in Italy
Overall | First-line therapy | Second-line therapy | Third-line therapy | ||
|---|---|---|---|---|---|
N | 208 | 147 | 112 | 41 | |
Patients with any surgery | N | 50 | 36 | 18 | 5 |
% | 24,0% | 24,5% | 16,1% | 12,2% | |
Type of surgery | |||||
Resection of primary tumor | % | 9% | 9% | 0% | 0% |
Lymph node resection | % | 21% | 16% | 3% | 2% |
All other visceral | % | 22% | 12% | 7% | 3% |
Brain metastases | % | 9% | 5% | 3% | 1% |
Isolated limb perfusion | % | 0% | 0% | 0% | 0% |
Biopsy | % | 12% | 9% | 2% | 1% |
Distant skin, subcutaneous or node | % | 12% | 9% | 3% | 0% |
Lung | % | 1% | 1% | 0% | 0% |
Total surgery cost per patient with any surgery (€ 2009) | Mean | 7.390 | 6.368 | 5.670 | 7.638 |
Total surgery cost per patient (€ 2009) | Mean | 1.776 | 1.560 | 911 | 931 |